Status:
UNKNOWN
NP-Supported Multidisciplinary Diabetes Management During Perioperative Period
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Roche Pharma AG
Conditions:
Diabetes
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The primary objective of this study is to determine the benefits of interventions from a Multidisciplinary Diabetes Care team involved of diabetes nurse practitioners(DNP) on glucose control, perioper...
Detailed Description
About 50% of diabetic patients will undergo at least one surgical operation, and nearly 20% of surgical patients have diabetes.Compared with non-diabetic patients, diabetic patients face greater risks...
Eligibility Criteria
Inclusion
- Diagnosis meets World Health Organization (WHO) (1999) Diabetes Diagnostic Standards
- Orthopedic assessment requires elective surgery and no surgical contraindications
- HbA1c≥8.5% or intravenous fasting blood glucose (FBG)\>10mmol/l
- Informed consent.
Exclusion
- Cognitive and communication disorders;
- Pregnancy;
- Participate in other intervention studies.
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 31 2023
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT05293015
Start Date
April 1 2022
End Date
March 31 2023
Last Update
March 23 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.